Lineage Cell Therapeutics, Inc. financial data

Symbol
LCTX on NYSE
Location
2173 Salk Avenue, Suite 200, Carlsbad, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 396 % +59.6%
Debt-to-equity 80.3 % +50.4%
Return On Equity -122 % -300%
Return On Assets -66.8 % -239%
Operating Margin -325 % -24.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 230M shares +22%
Common Stock, Shares, Outstanding 230M shares +22%
Entity Public Float 146M USD -21.2%
Common Stock, Value, Issued 494M USD +5.31%
Weighted Average Number of Shares Outstanding, Basic 229M shares +21.2%
Weighted Average Number of Shares Outstanding, Diluted 229M shares +21.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 10.8M USD +24.1%
Revenue from Contract with Customer, Excluding Assessed Tax 10.8M USD +24.1%
Cost of Revenue 272K USD -58.2%
Research and Development Expense 12.9M USD -0.32%
General and Administrative Expense 18M USD -0.27%
Costs and Expenses 46M USD +46.3%
Operating Income (Loss) -35.2M USD -54.8%
Nonoperating Income (Expense) -32.3M USD -1304%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -18.6M USD +20.2%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -67.7M USD -236%
Earnings Per Share, Basic 0 USD/shares -133%
Earnings Per Share, Diluted 0 USD/shares -133%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 40.5M USD +45.8%
Marketable Securities, Current 23K USD -99.5%
Accounts Receivable, after Allowance for Credit Loss, Current 127K USD -68.6%
Assets, Current 42.3M USD +22.8%
Property, Plant and Equipment, Net 2.16M USD +7.15%
Operating Lease, Right-of-Use Asset 2.31M USD -2.16%
Intangible Assets, Net (Excluding Goodwill) 31.7M USD -31.9%
Goodwill 10.7M USD 0%
Assets 89.6M USD -7.2%
Accounts Payable, Current 1.52M USD -4.94%
Employee-related Liabilities, Current 2.54M USD +2.01%
Accrued Liabilities, Current 486K USD +26.6%
Contract with Customer, Liability, Current 10.1M USD -72.4%
Liabilities, Current 9.38M USD -32.3%
Contract with Customer, Liability, Noncurrent 21.2M USD
Deferred Income Tax Liabilities, Net 273K USD 0%
Operating Lease, Liability, Noncurrent 1.52M USD -1.17%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 68.8M USD +116%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.29M USD -48.3%
Retained Earnings (Accumulated Deficit) -468M USD -16.9%
Stockholders' Equity Attributable to Parent 22M USD -66.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 20.8M USD -67.9%
Liabilities and Equity 89.6M USD -7.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.89M USD +15.5%
Net Cash Provided by (Used in) Financing Activities 5.04M USD -64%
Net Cash Provided by (Used in) Investing Activities 1.9M USD
Common Stock, Shares Authorized 450M shares 0%
Common Stock, Shares, Issued 230M shares +22%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.99M USD -75.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 41M USD +44.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 14K USD +600%
Deferred Tax Assets, Valuation Allowance 86.3M USD +7.21%
Deferred Tax Assets, Gross 93.4M USD +9.61%
Operating Lease, Liability 2.54M USD -2.98%
Payments to Acquire Property, Plant, and Equipment 97K USD +155%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -69.1M USD -230%
Operating Lease, Liability, Current 1.02M USD -5.54%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Deferred Tax Assets, Operating Loss Carryforwards 68.2M USD +7.44%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2M shares 0%
Unrecognized Tax Benefits 3.15M USD +6.41%
Operating Lease, Payments 305K USD +0.99%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 0 USD -100%
Depreciation, Depletion and Amortization 138K USD -8%
Deferred Tax Assets, Net of Valuation Allowance 7.11M USD +50.6%
Share-based Payment Arrangement, Expense 4.97M USD +3.05%